[Monoclonal antibody 17-1A (Panorex). A new approach to adjuvant therapy of colonic carcinoma].
Illiger
H J
HJ
Städtische Kliniken Oldenburg, Klinik für Innere Medizin II, Onkologie/Hämatologie.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D000918:Antibody Specificity; D000951:Antigens, Neoplasm / Q000276:immunology*; D003110:Colonic Neoplasms / Q000276:immunology / Q000628:therapy*; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D051379:Mice; D018365:Neoplasm, Residual / Q000628:therapy
D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; C050928:carcinoma-associated antigen 17-1A